Evidence map›Paper›PMID 39950466›Full record

ArticleProtein and peptide letters2025

Inconsistent Protein Stability Despite Pre-HECT Domain Helix: Unveiling Variability in HECT Ligases.

Cagdas Dag, Cansu Deniz Tozkoparan Ceylan, Cemre Sare Cansız

Abstract read
PubMed Publisher
In one paragraph

Article in Protein and peptide letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Cagdas DagNanofabrication and Nanocharacterization Center for Scientific and Technological Advanced Research (n2STAR), Koç University, İstanbul, Türkiye.ORCID 0000-0003-1595-431X
Cansu Deniz Tozkoparan CeylanNanofabrication and Nanocharacterization Center for Scientific and Technological Advanced Research (n2STAR), Koç University, İstanbul, Türkiye.
Cemre Sare CansızNanofabrication and Nanocharacterization Center for Scientific and Technological Advanced Research (n2STAR), Koç University, İstanbul, Türkiye.

Funding

TÜBİTAK, Türkiye Bilimsel ve Teknolojik Araştırma Kurumu 120Z594
6 · The paper itself

Abstract

introductionUbiquitin and ubiquitin-like systems play crucial roles across a wide range of organisms, from simple to complex. Among the three enzyme-mediated post-translational modification (PTM) steps, the ligation step is the most critical. HERC5, a member of the HECT ligase family, is one of the three enzymes involved in the ISGylation system. However, the precise start points and lengths of the HECT domains in HECT ligases are still under debate.

methodsSome studies suggest the inclusion of an additional N-terminal alpha helix region within the HECT domain. To investigate the structural biology of the HECT domain of HERC5, we produced and purified various lengths of the HERC5 HECT domain using different fusion proteins. This approach allowed us to explore the role of the N-terminal alpha helix in the stability of the HECT domain. Our experiments successfully produced and purified HERC5 HECT domains of different lengths with various fusion proteins.

resultsThe findings demonstrated that the N-terminal alpha-helix does not enhance the stability of the HECT domain. These results challenge the notion that the N-terminal alpha-helix should be generally included in the HECT domain across all HECT ligases.

conclusionThe inclusion of this region within the HECT domain may not be appropriate for generalization, as it does not contribute to stability, contrary to some previous suggestions.

Indexed as

Ubiquitin-Protein LigasesHumansProtein Conformation, alpha-HelicalProtein DomainsProtein StabilityRecombinant Fusion ProteinsRecombinant Fusion ProteinsUbiquitin-Protein LigasesbiotechnologyEscherichia coli.HECT ligaseHERC5ISGylationubiquitin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.